Insulet Statistics
Total Valuation
Insulet has a market cap or net worth of $17.33 billion. The enterprise value is $17.79 billion.
Important Dates
The next confirmed earnings date is Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Insulet has 70.23 million shares outstanding. The number of shares has increased by 0.35% in one year.
| Current Share Class | 70.23M |
| Shares Outstanding | 70.23M |
| Shares Change (YoY) | +0.35% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 0.34% |
| Owned by Institutions (%) | 101.87% |
| Float | 69.91M |
Valuation Ratios
The trailing PE ratio is 42.67 and the forward PE ratio is 59.16. Insulet's PEG ratio is 2.34.
| PE Ratio | 42.67 |
| Forward PE | 59.16 |
| PS Ratio | 8.34 |
| Forward PS | 6.93 |
| PB Ratio | 14.28 |
| P/TBV Ratio | 16.31 |
| P/FCF Ratio | 56.68 |
| P/OCF Ratio | 40.23 |
| PEG Ratio | 2.34 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 45.65, with an EV/FCF ratio of 58.25.
| EV / Earnings | 42.53 |
| EV / Sales | 8.59 |
| EV / EBITDA | 45.65 |
| EV / EBIT | 57.59 |
| EV / FCF | 58.25 |
Financial Position
The company has a current ratio of 3.58, with a Debt / Equity ratio of 1.18.
| Current Ratio | 3.58 |
| Quick Ratio | 2.50 |
| Debt / Equity | 1.18 |
| Debt / EBITDA | 3.61 |
| Debt / FCF | 4.70 |
| Interest Coverage | 7.23 |
Financial Efficiency
Return on equity (ROE) is 43.03% and return on invested capital (ROIC) is 8.00%.
| Return on Equity (ROE) | 43.03% |
| Return on Assets (ROA) | 6.80% |
| Return on Invested Capital (ROIC) | 8.00% |
| Return on Capital Employed (ROCE) | 12.07% |
| Revenue Per Employee | $531,179 |
| Profits Per Employee | $107,256 |
| Employee Count | 3,900 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 1.50 |
Taxes
| Income Tax | -118.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.10% in the last 52 weeks. The beta is 1.30, so Insulet's price volatility has been higher than the market average.
| Beta (5Y) | 1.30 |
| 52-Week Price Change | +50.10% |
| 50-Day Moving Average | 262.78 |
| 200-Day Moving Average | 243.79 |
| Relative Strength Index (RSI) | 44.19 |
| Average Volume (20 Days) | 808,326 |
Short Selling Information
The latest short interest is 2.40 million, so 3.41% of the outstanding shares have been sold short.
| Short Interest | 2.40M |
| Short Previous Month | 2.88M |
| Short % of Shares Out | 3.41% |
| Short % of Float | 3.43% |
| Short Ratio (days to cover) | 2.68 |
Income Statement
In the last 12 months, Insulet had revenue of $2.07 billion and earned $418.30 million in profits. Earnings per share was $5.78.
| Revenue | 2.07B |
| Gross Profit | 1.45B |
| Operating Income | 308.90M |
| Pretax Income | 267.50M |
| Net Income | 418.30M |
| EBITDA | 389.70M |
| EBIT | 308.90M |
| Earnings Per Share (EPS) | $5.78 |
Full Income StatementBalance Sheet
The company has $953.40 million in cash and $1.43 billion in debt, giving a net cash position of -$480.80 million or -$6.85 per share.
| Cash & Cash Equivalents | 953.40M |
| Total Debt | 1.43B |
| Net Cash | -480.80M |
| Net Cash Per Share | -$6.85 |
| Equity (Book Value) | 1.21B |
| Book Value Per Share | 17.26 |
| Working Capital | 1.36B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $430.30 million and capital expenditures -$124.90 million, giving a free cash flow of $305.40 million.
| Operating Cash Flow | 430.30M |
| Capital Expenditures | -124.90M |
| Free Cash Flow | 305.40M |
| FCF Per Share | $4.35 |
Full Cash Flow StatementMargins
Gross margin is 69.79%, with operating and profit margins of 14.91% and 20.19%.
| Gross Margin | 69.79% |
| Operating Margin | 14.91% |
| Pretax Margin | 14.49% |
| Profit Margin | 20.19% |
| EBITDA Margin | 18.81% |
| EBIT Margin | 14.91% |
| FCF Margin | 14.74% |
Dividends & Yields
Insulet does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.35% |
| Shareholder Yield | -0.35% |
| Earnings Yield | 2.42% |
| FCF Yield | 1.76% |
Dividend DetailsAnalyst Forecast
The average price target for Insulet is $294.65, which is 19.39% higher than the current price. The consensus rating is "Buy".
| Price Target | $294.65 |
| Price Target Difference | 19.39% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 15.33% |
| EPS Growth Forecast (5Y) | 7.96% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Insulet has an Altman Z-Score of 6.17 and a Piotroski F-Score of 8.
| Altman Z-Score | 6.17 |
| Piotroski F-Score | 8 |